Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company’s work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
The post Science Corporation implants its vision-restoring chip in its first Stargardt disease patient appeared first on TechCrunch.
